These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 29923617)

  • 1. CD93 regulates central nervous system inflammation in two mouse models of autoimmune encephalomyelitis.
    Griffiths MR; Botto M; Morgan BP; Neal JW; Gasque P
    Immunology; 2018 Nov; 155(3):346-355. PubMed ID: 29923617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD93/AA4.1: a novel regulator of inflammation in murine focal cerebral ischemia.
    Harhausen D; Prinz V; Ziegler G; Gertz K; Endres M; Lehrach H; Gasque P; Botto M; Stahel PF; Dirnagl U; Nietfeld W; Trendelenburg G
    J Immunol; 2010 Jun; 184(11):6407-17. PubMed ID: 20439917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.
    Berard JL; Zarruk JG; Arbour N; Prat A; Yong VW; Jacques FH; Akira S; David S
    Glia; 2012 Jul; 60(7):1145-59. PubMed ID: 22499213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nod-like receptor, Nlrp12, plays an anti-inflammatory role in experimental autoimmune encephalomyelitis.
    Gharagozloo M; Mahvelati TM; Imbeault E; Gris P; Zerif E; Bobbala D; Ilangumaran S; Amrani A; Gris D
    J Neuroinflammation; 2015 Oct; 12():198. PubMed ID: 26521018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A4 promotes experimental autoimmune encephalomyelitis by impacting microglial inflammation through TLR4/NF-κB signaling pathway.
    Jingjing H; Tongqian W; Shirong Y; Lan M; Jing L; Shihui M; Haijian Y; Fang Y
    Int Immunopharmacol; 2024 Dec; 142(Pt A):112849. PubMed ID: 39241524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRP1 expression in microglia is protective during CNS autoimmunity.
    Chuang TY; Guo Y; Seki SM; Rosen AM; Johanson DM; Mandell JW; Lucchinetti CF; Gaultier A
    Acta Neuropathol Commun; 2016 Jul; 4(1):68. PubMed ID: 27400748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of the C5a receptor gene fails to protect against experimental allergic encephalomyelitis.
    Reiman R; Gerard C; Campbell IL; Barnum SR
    Eur J Immunol; 2002 Apr; 32(4):1157-63. PubMed ID: 11932923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
    Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
    Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination.
    Gran B; Zhang GX; Yu S; Li J; Chen XH; Ventura ES; Kamoun M; Rostami A
    J Immunol; 2002 Dec; 169(12):7104-10. PubMed ID: 12471147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR2-dependent dendritic cell accumulation in the central nervous system during early effector experimental autoimmune encephalomyelitis is essential for effector T cell restimulation in situ and disease progression.
    Clarkson BD; Walker A; Harris MG; Rayasam A; Sandor M; Fabry Z
    J Immunol; 2015 Jan; 194(2):531-41. PubMed ID: 25505278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiopoietin-2 blockade ameliorates autoimmune neuroinflammation by inhibiting leukocyte recruitment into the CNS.
    Li Z; Korhonen EA; Merlini A; Strauss J; Wihuri E; Nurmi H; Antila S; Paech J; Deutsch U; Engelhardt B; Chintharlapalli S; Koh GY; Flügel A; Alitalo K
    J Clin Invest; 2020 Apr; 130(4):1977-1990. PubMed ID: 32149735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and glia cells.
    Xiao Y; Lai L; Chen H; Shi J; Zeng F; Li J; Feng H; Mao J; Zhang F; Wu N; Xu Y; Tan Z; Gong F; Zheng F
    Mol Immunol; 2018 Sep; 101():550-563. PubMed ID: 30173119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD93 is a cell surface lectin receptor involved in the control of the inflammatory response stimulated by exogenous DNA.
    Nativel B; Ramin-Mangata S; Mevizou R; Figuester A; Andries J; Iwema T; Ikewaki N; Gasque P; Viranaïcken W
    Immunology; 2019 Oct; 158(2):85-93. PubMed ID: 31335975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis.
    Tsutsui S; Schnermann J; Noorbakhsh F; Henry S; Yong VW; Winston BW; Warren K; Power C
    J Neurosci; 2004 Feb; 24(6):1521-9. PubMed ID: 14960625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High interleukin-10 expression within the central nervous system may be important for initiation of recovery of Dark Agouti rats from experimental autoimmune encephalomyelitis.
    Blaževski J; Petković F; Momčilović M; Jevtic B; Miljković D; Mostarica Stojković M
    Immunobiology; 2013 Sep; 218(9):1192-9. PubMed ID: 23664544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity of innate immune cell subsets across spatial and temporal scales in an EAE mouse model.
    Caravagna C; Jaouën A; Desplat-Jégo S; Fenrich KK; Bergot E; Luche H; Grenot P; Rougon G; Malissen M; Debarbieux F
    Sci Rep; 2018 Mar; 8(1):5146. PubMed ID: 29572472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis.
    Wen J; Ribeiro R; Tanaka M; Zhang Y
    Neuropharmacology; 2015 Dec; 99():196-209. PubMed ID: 26189763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage galactose-type lectin (MGL) is induced on M2 microglia and participates in the resolution phase of autoimmune neuroinflammation.
    Ilarregui JM; Kooij G; Rodríguez E; van der Pol SMA; Koning N; Kalay H; van der Horst JC; van Vliet SJ; García-Vallejo JJ; de Vries HE; van Kooyk Y
    J Neuroinflammation; 2019 Jun; 16(1):130. PubMed ID: 31248427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis.
    Abdul-Majid KB; Stefferl A; Bourquin C; Lassmann H; Linington C; Olsson T; Kleinau S; Harris RA
    Scand J Immunol; 2002 Jan; 55(1):70-81. PubMed ID: 11841694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis.
    Juedes AE; Ruddle NH
    J Immunol; 2001 Apr; 166(8):5168-75. PubMed ID: 11290800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.